MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ajo.2019.04.017

Медицинская библиотека · American journal of ophthalmology · 2019

Incidence, Epidemiology, and Transformation of Ocular Myasthenia Gravis: A Population-Based Study.

Hendricks Tina M, Bhatti M Tariq, Hodge David O, Chen John J

СтатьяМногоцентровое исследованиеПоддержка NIH: внешняя программаПеревод пока не подготовлен

Аннотация

PURPOSE: To establish the incidence of ocular myasthenia gravis (OMG) as well as identify determinants of transformation to generalized myasthenia gravis (GMG) using a population-based record-linkage system.

DESIGN

Population-based, retrospective cohort study.

METHODS

All adults (≥18 years) diagnosed with myasthenia gravis (MG) from January 1, 1990, through December 31, 2017, were identified using the Rochester Epidemiology Project. Sixty-five patients with MG were identified. Data were collected regarding symptom onset, diagnostic testing results, and conversion from OMG to GMG.

RESULTS

Median follow-up time was 91 months (range 17-333 months). The annual incidence of MG was 2.20/100 000 with a mean age at diagnosis of 59 years (SD=17) and 62% male sex. Thirty-three (51%) of the 65 patients presented with OMG, providing an annual incidence of 1.13/100 000. Eighteen (55%) of the 33 patients presenting with OMG converted to GMG at a median time of 13 months (range 2-180 months). Sixteen (67%) of 24 OMG patients who were seropositive for acetylcholine receptor antibody (AchR Ab) converted to GMG at 5 years compared to 11% (1/9) of those who were seronegative (hazard ratio [HR], 8.2, P = .04). Ten (77%) of 13 OMG patients with a positive single-fiber electromyography (sfEMG) at diagnosis converted to GMG at 5 years, compared with 18% (2/11) of patients who had a negative sfEMG (HR, 5.5, P = .01).

CONCLUSIONS

In our population-based study, 51% (33/65) of patients with MG presented with isolated ocular involvement, with 55% (18/33) of these patients converting to GMG at some point in the course of their disease. Positive sfEMG and AchR Ab seropositivity at the time of diagnosis increased the risk of conversion to GMG.

Для цитирования: Hendricks Tina M, Bhatti M Tariq, Hodge David O, Chen John J. Incidence, Epidemiology, and Transformation of Ocular Myasthenia Gravis: A Population-Based Study.. American journal of ophthalmology. 2019. DOI: 10.1016/j.ajo.2019.04.017.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.